Company
InCarda Therapeutics Inc.
Developing novel treatments for patients with atrial fibrillation
Also known as InCarda Therapeutics
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- West Jordan, UT, United States
- Legal name
- InCarda Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
We are developing drugs designed to safety, effectively, and quickly get patients back to where they belong - in normal sinus rhythm.
Funding snapshot
- Total raised
- $66.3MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $28M2020-10-06
Funding rounds
- Round, 2020
- $28M2020-10-06, SEC form D sold, 5 investors
- Round, 2017
- $35.3M2017-10-20, SEC form D sold, 24 investors
- Round, 2017
- $2.1M2017-03-09, SEC form D sold, 16 investors
- Round, 2013
- $567K2013-09-03, SEC form D sold, 13 investors
- Round, 2011
- $310K2011-07-21, SEC form D sold, 5 investors
Loading relationship preview